| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| sotorasib nsclc | 1.29 | 0.3 | 9134 | 22 | 15 |
| sotorasib | 0.97 | 0.6 | 3076 | 43 | 9 |
| nsclc | 0.37 | 0.3 | 4356 | 50 | 5 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| sotorasib nsclc | 0.34 | 0.4 | 7343 | 92 |
| sotorasib first line nsclc | 1.87 | 0.6 | 4050 | 78 |
| sotorasib approval nsclc | 0.27 | 0.6 | 6106 | 78 |
| sotorasib and nsclc | 0.37 | 1 | 7461 | 63 |
| first line therapy for nsclc | 0.59 | 0.7 | 8542 | 65 |
| nsclc first line treatment | 0.01 | 0.1 | 2443 | 4 |
| first line treatment of advanced nsclc | 0.01 | 0.7 | 6955 | 87 |
| first line chemotherapy for nsclc | 1.4 | 0.5 | 4928 | 40 |
| si-b001 nsclc | 0.18 | 0.7 | 3379 | 87 |
| up to date nsclc | 1.79 | 0.6 | 6611 | 94 |
| atezolizumab 1st line nsclc | 0.95 | 0.1 | 5081 | 6 |
| ns-nsclc | 0.07 | 0.9 | 9150 | 69 |
| sclc first line treatment | 1.54 | 0.5 | 831 | 87 |
| nsclc transformation to sclc | 1.55 | 0.6 | 1058 | 55 |
| nsclc-sm | 1.03 | 0.3 | 9422 | 59 |
| nsclc/bc/hnscc | 1.46 | 0.3 | 5972 | 95 |
| nsclc-lm | 1.11 | 0.3 | 3717 | 94 |
